0% found this document useful (0 votes)
25 views24 pages

Art42755 Sup 0001 Disclosureform

The ICMJE Disclosure Form is completed by multiple authors for a manuscript titled 'Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural interventions for rheumatoid arthritis fatigue: an MRI brain study.' Each author discloses that they have no relationships, activities, or interests related to the manuscript, indicating a commitment to transparency. The form emphasizes the importance of declaring any potential conflicts of interest to maintain integrity in the research process.

Uploaded by

chengwei6026
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
25 views24 pages

Art42755 Sup 0001 Disclosureform

The ICMJE Disclosure Form is completed by multiple authors for a manuscript titled 'Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural interventions for rheumatoid arthritis fatigue: an MRI brain study.' Each author discloses that they have no relationships, activities, or interests related to the manuscript, indicating a commitment to transparency. The form emphasizes the importance of declaring any potential conflicts of interest to maintain integrity in the research process.

Uploaded by

chengwei6026
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 24

ICMJE DISCLOSURE FORM

Date:__10/10/2023___________________________________________________________________________________
Your Name:_______AMIR DEHSARVI_____________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__13/10/2023___________________________________________________________________________________
Your Name:___________Salim Al-Wasity__________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__10/10/2023___________________________________________________________________________________
Your Name: Kristian Stefanov ___________________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__13/10/2023___________________________________________________________________________________
Your Name:_________Stewart Wiseman__________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__10/10/2023___________________________________________________________________________________
Your Name:___Stuart H Ralston________________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__10/10/2023___________________________________________________________________________________
Your Name:___Joanna M Wardlaw______________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present Chief Scientist Office of the Funded the research
manuscript (e.g., funding, Scottish Govt (TCS/17/14)
provision of study materials,
medical writing, article UK Dementia Research Part funding for JMW
processing charges, etc.) Institute which is funded
No time limit for this item. by the UK MRC,
Alzheimer’s Society and
Alzheimer’s Research UK
The Stroke Association Part Fellowship funding for S Wiseman

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None

5 Payment or honoraria for ____None


lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__12/10/2023___________________________________________________________________________________
Your Name:____Richard Emsley_________________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__10/10/2023___________________________________________________________________________________
Your Name:__Eva-Maria Bachmair_______________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial
planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__10/10/2023___________________________________________________________________________________
Your Name:______JONATHAN CAVANAGH
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__12/10/2023___________________________________________________________________________________
Your Name:____Gordon Waiter_________________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present IDENTIFYING FATIQUE BIOMARKERS IN RHEMATOID
manuscript (e.g., funding, ARTHRITIS USING MULTI-MODAL NEUROIMAGING.
provision of study materials, Roland Sutton Academic Waiter, G.
medical writing, article Trust ROLAND SUTTON ACADEMIC TRUST: £54,199.00
processing charges, etc.) 1/01/19 → 28/02/21
No time limit for this item. Award date: 10/12/18
DELINEATING THE NERUAL MEDIATORS OF
RHEUMATOID ARTHRITIS RELATED FATIGUE (LIFT TRIAL
ADD-ON)
Waiter, G.
Versus Arthritis
VERSUS ARTHRITIS (PREVIOUSLY ARTHRITIS RESEARCH
UK): £11,581.51
1/10/17 → 30/04/21
Award date: 30/04/20
UNDERLYING NEURAL MECHANISMS OF FATIGUE IN
Roland Sutton Academic RHEUMATOID ARTHRITIS
Trust Waiter, G.
ROLAND SUTTON ACADEMIC TRUST: £23,744.00
1/03/21 → 31/07/21
Award date: 1/02/21
Brain predictors of fatigue in Rheumatoid Arthritis: a
machine learning study - Publication fees
Roland Sutton Academic Waiter, G.
Trust Roland Sutton Academic Trust: £2,000.00
1/12/21 → 30/11/22
Award date: 2/12/21
Time frame: past 36 months
2 Grants or contracts from Dissemination of radiological impact of field-cycling MRI
any entity (if not indicated for brain imaging applications and early career
in item #1 above). researcher support
Roland Sutton Academic
Senn de Vries, N., MacLeod, M. & Waiter, G.
Trust
Roland Sutton Academic Trust: £6,576.13
1/07/23 → 30/06/24
Award date: 25/07/23
Investigating the impact of Brain Iron on
Neurodegeneration – biochemistry costs
Roland Sutton Academic Waiter, G.
Trust Roland Sutton Academic Trust: £2,575.00
1/08/22 → 31/07/23
Award date: 19/08/22
Seeing through the chemofog: A pilot study to determine
the neural correlates of chemotherapy induced cognitive
impairment
Friends of ANCHOR Waiter, G., Elsberger, B. & McNeil, C.
Friends of ANCHOR: £14,909.00
1/08/22 → 31/01/24
Award date: 20/05/22
Seeing through the chemofog: Neural correlates of
chemotherapy induced cognitive impairment
NHS Grampian Waiter, G., Elsberger, B. & McNeil, C.
Endowments Nhs Grampian Endowments: £11,785.00
1/04/22 → 31/03/24
Award date: 1/04/22
Effect of Radiofrequency denervation on Brain structure,
function and connectivity in chronic Low Back Pain
patients – a pilot study
Scottish Imaging Network:
Waiter, G.
A Platform for Scientific
Scottish Imaging Network: A Platform for Scientific
Excellence
Excellence: £4,394.80
1/04/22 → 30/06/24
Award date: 16/03/22
Brain predictors of fatigue in Rheumatoid Arthritis: a
machine learning study - Publication fees
Roland Sutton Academic Waiter, G.
Trust Roland Sutton Academic Trust: £2,000.00
1/12/21 → 30/11/22
Award date: 2/12/21
Characterising the Centralised Pain Phenotype in Chronic
Versus Arthritis Rheumatic Disease - A Stride Towards Personalised
Analgesia
Macfarlane, G., Hollick, R., Jones, G. & Waiter, G.
Versus Arthritis: £11,134.00
3/01/19 → 2/07/23
Award date: 20/07/21
Early detection of Alzheimer’s disease with glucoCEST
MRI; a proof of concept study
Waiter, G. & Myint, P.
Scottish Government -
Scottish Government - Chief Scientist Office:
Chief Scientist Office
£260,978.55
1/01/22 → 31/07/24
Award date: 16/07/21
The Impact of Brain Iron Deposition on Age-related
Cognitive Decline
Waiter, G. & McNeil, C.
Alzheimer’s Research UK
Alzheimer´s Research UK: £2,870.40
1/07/21 → 30/06/22
Award date: 11/05/21
3 Royalties or licenses ____None

4 Consulting fees ____None

5 Payment or honoraria for ____None


lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.
ICMJE DISCLOSURE FORM

Date:__10/10/2023___________________________________________________________________________________
Your Name:_______Neil Basu__________________________________________________________________________
Manuscript Title: Characterising the neurobiological mechanisms of action of exercise and cognitive behavioural
interventions for rheumatoid arthritis fatigue: an MRI brain study.
Manuscript number (if known):__ ar-23-1080.R1___________________________________________________________

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are
related to the content of your manuscript. “Related” means any relation with for-profit or not-for-profit third
parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment
to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a
relationship/activity/interest, it is preferable that you do so.

The following questions apply to the author’s relationships/activities/interests as they relate to the current
manuscript only.

The author’s relationships/activities/interests should be defined broadly. For example, if your manuscript pertains
to the epidemiology of hypertension, you should declare all relationships with manufacturers of antihypertensive
medication, even if that medication is not mentioned in the manuscript.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items,
the time frame for disclosure is the past 36 months.

Name all entities with Specifications/Comments


whom you have this (e.g., if payments were made to you or to your
relationship or indicate institution)
none (add rows as
needed)
Time frame: Since the initial planning of the work
1 All support for the present ____None
manuscript (e.g., funding,
provision of study materials,
medical writing, article
processing charges, etc.)
No time limit for this item.

Time frame: past 36 months


2 Grants or contracts from ____None
any entity (if not indicated
in item #1 above).
3 Royalties or licenses ____None

4 Consulting fees ____None


5 Payment or honoraria for ____None
lectures, presentations,
speakers bureaus,
manuscript writing or
educational events
6 Payment for expert ____None
testimony

7 Support for attending ____None


meetings and/or travel

8 Patents planned, issued or ____None


pending

9 Participation on a Data ____None


Safety Monitoring Board or
Advisory Board
10 Leadership or fiduciary role ____None
in other board, society,
committee or advocacy
group, paid or unpaid
11 Stock or stock options ____None

12 Receipt of equipment, ____None


materials, drugs, medical
writing, gifts or other
services
13 Other financial or non- ____None
financial interests

Please place an “X” next to the following statement to indicate your agreement:

_X_ I certify that I have answered every question and have not altered the wording of any of the questions on this
form.

You might also like